A Novel Variant in the Cacna1s Gene Associated with Hypokalemic Periodic Paralysis: A Case Report

Authors

DOI:

https://doi.org/10.24950/rspmi/CC/153/1/2019

Keywords:

Calcium Channels/genetics, Genetic Predisposition to Disease, Hypokalemic Periodic Paralysis, Mutation

Abstract

Hypokalemic periodic paralysis is a rare condition secondary to a genetic abnormality in calcium or sodium voltage
dependent ion channels. It typically presents with muscle
weakness and concomitant low serum concentration of potassium after exercise or emotional distress. We report the
case of a woman who presented with flaccid tetraparesis
and severe hypokalemia in which we have identified a novel probably disease-causing variant in the CACNA1S gene.
After the diagnosis, the patient started acetazolamide treatment, resulting in a reduction in the intensity and number of
episodes. Hypokalemic periodic paralysis is a rare cause
of sudden muscle weakness. It may cause life-threatening
respiratory involvement and cardiac arrhythmias, so all the
clinicians should be aware of this condition in order to recognize it quickly

Downloads

Download data is not yet available.

References

Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: An autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord. 1997;7:234–40.

Dogan NO, Avcu N, Yaka E, Isikkent A, Durmus U. Weakness in the Emergency Department: Hypokalemic Periodic Paralysis Induced By Strenuous Physical Activity. Turkish J Emerg Med . 2015;15:93–5.

Wang X, Ren B, Yong Z, Xu H, Fu Q, Yao H. Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. Mol Med Rep. 2015;6267–74. doi: 10.3892/mmr.2015.4201

Kim JB, Kim JB, Kang SY, Yi JW, Kim SM. The large-conductance calcium-activated potassium channel holds the key to the conundrum of familial hypokalemic periodic paralysis. Korean J Pediatr. 2014;57:446–51. doi: 10.3345/kjp.2014.57

Kantola IM, Tarssanen LT. Familial hypokalaemic periodic paralysis in Finland. J Neurol Neurosurg Psychiatry. 1992;55:322–4.

Matthews E, Labrum R, Sweeney MG, Sud R, Haworth A, Chinnery PF, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology. 2009;72:1544–7. doi: 10.1212/01. wnl.0000342387.65477.

Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R, et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med. 2005;83:203–8.

Matthews E, Portaro S, Ke Q, Sud R, Haworth A, Davis MB, et al. Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology. 2011;77:1960–4. doi: 10.1212/ WNL.0b013e31823a0cb6.

Matthews E, Hanna MG. Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis? J Physiol. 2010;588:1879–86. doi: 10.1113/jphysiol.2009.186627.

Ke Q, He F, Lu L, Yu P, Jiang Y, Weng C, et al. The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis. Neuromuscul Disord. 2015; 25):955-8. doi: 10.1016/j. nmd.2015.09.006.

Stedwell RAYE, Allen KM, Binder LS. Hypokalemic Paralyses. Am J Emerg Med. 1992;10:143–8.

Published

2019-03-15

How to Cite

1.
A. Maia C, Hipólito-Reis A, Pinho O, Alonso I, Vasco Barreto J. A Novel Variant in the Cacna1s Gene Associated with Hypokalemic Periodic Paralysis: A Case Report. RPMI [Internet]. 2019 Mar. 15 [cited 2024 Dec. 18];26(1):47-9. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/365

Issue

Section

Case Reports